Researchers at the National Institutes of Health (NIH) have conducted a small-scale study that suggests positron emission tomography (PET) scans of the heart can potentially identify individuals at risk of developing Parkinson’s disease or Lewy body dementia.
Published in the Journal of Clinical Investigation and led by scientists at the National Institute of Neurological Disorders and Stroke (NINDS), this research offers promise in detecting the earliest signs that may eventually lead to these debilitating neurological conditions.
The Link Between Heart Scans and Neurological Diseases
Parkinson’s disease is a systemic autoimmune inflammatory disease characterized by chronic joint inflammation, which leads to joint damage and loss of function.
It can also affect tissues and organs outside the joints, including (but not limited to) the eyes, heart, and lungs.
Nonalcoholic fatty liver disease (NAFLD), although not a classic complication of RA, is prevalent among RA patients, affecting about 35% of men and 22% of women.
Previous research suggested that HCQ might lower the risk, so rheumatologist Hsin-Hua Chen, MD, Ph.D., and colleagues at Taichung Veterans General Hospital in Taichung City, Taiwan, decided to explore the association between HCQ and NAFLD in a nationwide RA cohort.
The researchers drew on population-based claims data from the National Health Insurance Research Database in Taiwan from 2000 to 2020.
The study included more than 21,000 patients, with a mean standard deviation age of 51.9, and the ratio of women to men was 3 to 2.
A time-varying, multivariable Cox regression model was used to estimate the adjusted hazard ratios with 95% confidence interval for an association between HCQ and NAFLD, after adjusting for potential confounders.
Subgroup analyses looked at patients based on sex and age (men and women younger and older than 50).
The study’s results show that 399 (1.86%) patients developed NAFLD after more than eight years. The study also suggests that taking HCQ was associated with a significantly lower risk of NAFLD, especially in women younger than 50.
Chen says this association may be due to the effect of HCQ on adiponectin, an adipokine inversely linked to insulin resistance, inflammation and NAFLD.
“The mechanism of decreasing the risk of NAFLD by HCQ may be its [ability] to increase adiponectin levels,” Chen says.
“Estrogen has been reported to inhibit adiponectin production and estrogens are inversely associated with adiponectin levels. Therefore, the reduced NAFLD risk with HCQ may be more prominent in premenopausal women.”
The study found other common risk factors for NAFLD, including obesity, higher doses of prednisone and nonsteroidal anti-inflammatory drugs (NSAIDs).
However, typical risk factors, like diabetes and high cholesterol, were not in this RA cohort. (A smaller study by Wiemer et al. presented at ACR Convergence 2020 did find a high degree of diabetes among RA patients taking HCQ).
If you care about dementia, please read studies about how the Mediterranean diet could protect your brain health, and Vitamin B supplements could help reduce dementia risk.
For more information about brain health, please see recent studies that high-fiber diet could help lower the dementia risk, and these antioxidants could help reduce dementia risk.
The research findings can be found in the Journal of Clinical Investigation.
Follow us on Twitter for more articles about this topic.
Copyright © 2023 Knowridge Science Report. All rights reserved.
